Want to track AIM and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
AIM ImmunoTech Inc. (AIM) Statistics
Valuation metrics
Market Cap 1.57M
Enterprise value 139.5K
Trailing P/E (ttm) -0.13
Forward P/E -
PEG ratio -0
Price/Sales (ttm) 14.7
Price/Book (mrq) 0.83
Enterprise Value/Revenue 1.48
Enterprise Value/EBITDA -0.01
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 1.96M
Average volume (90 days) 15.81M
Price summary
52-Week low 0.21
52-Week high 19.74
Beta -
50-Day moving average 0.4
200-Day moving average 0.91
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date -
Ex-Dividend Date -
Last split factor 1,031:1,000
Last split Date 10 Feb 2026
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -141.23%
Operating margin -108.39%
Operational effectiveness
Return on assets -1.55%
Return on equity 2.62%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 0.02
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -3.05
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 1.35
Total debt (mrq) -
Total Debt/Equity (mrq) 2.15
Current ratio (mrq) 1.01%
Book value per share (mrq) 0.49
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
